Stem Cells And Myocardial Regeneration
Over the past 5 years there has been great excitement and controversy in the scientific, financial, and lay literature for the potential of stem cell-based strategies for the prev- tion and treatment of chronic heart failure (CHF). Not that long ago we believed we were born with a set number of card...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Totowa, NJ :
Humana Press,
2007.
|
Σειρά: | Contemporary Cardiology
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Economic impact of heart failure
- The Challenge for Stem Cell Therapy
- Cells Of Interest For Myocardial Regeneration
- Hematopoietic Stem Cells for Myocardial Regeneration
- Mesenchymal Stem Cells for Cardiac Therapy
- Multipotent Adult Progenitor Cells
- Mesenchymal Progenitor Cells for Vascular Network Formation and Cardiac Muscle Regeneration
- Umbilical Cord Blood Stem Cells for Myocardial Regeneration and Angiogenesis
- Endogenous Cardiac Stem Cells
- Embryonic Stem Cells for Myocardial Repair
- Mechanisms And Critical Pathways Involved In Myocardial Repair
- Chemokine and Homing Factor Expression in Acute Myocardial Infarction and Chronic Heart Failure
- Stem Cell Differentiation Toward a Cardiac Myocyte Phenotype
- Electrical Coupling and/or Ventricular Tachycardia Risk of Cell Therapy
- Cell Therapy for Myocardial Damage
- Strategies For Cell Delivery: Advantages/Disadvantages
- Aspects of Percutaneous Cellular Cardiomyoplasty
- Stem Cells and Myocardial Regeneration
- Stem Cell-Based Clinical Trials For Cardiac Dysfunction
- Measures of Effective Cell-Based Therapy
- Whole Bone Marrow Transplantation
- Clinical Angioblast Therapy
- Use of Skeletal Myoblasts for the Treatment of Chronic Heart Failure
- Bone Marrow and Angioblast Transplantation
- Strategies for Cytokine Modification and Stem Cell Mobilization for Acute Myocardial Infarction
- Summary/Future Challenges
- Summary and Future Challenges.